Regencell Bioscience Holdings (RGC) Shares Outstanding (Weighted Average) (2020 - 2023)
Regencell Bioscience Holdings (RGC) reported Shares Outstanding (Weighted Average) of $494.5 million for Q2 2023, up 4844.89% quarter-over-quarter from $10.0 million in Q2 2020.
Regencell Bioscience Holdings (RGC) Shares Outstanding (Weighted Average) (2020 - 2023) Analysis & Trends
Regencell Bioscience Holdings has reported Shares Outstanding (Weighted Average) for 2 years, with the latest figure at $494.5 million in Q2 2023.
- For the quarter ending Q2 2023, Shares Outstanding (Weighted Average) changed N/A year-over-year to $494.5 million; the trailing twelve-month figure through Jun 2023 stood at $494.5 million (changed N/A YoY), and the FY2023 full-year result was $494.5 million, changed N/A from the prior year.
- Shares Outstanding (Weighted Average) for Q2 2023 stood at $494.5 million, up from $10.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $494.5 million in Q2 2023, with the low at $10.0 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 5.02 Bn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 100.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 64.74 Mn |
| 10 | Regencell Bioscience Holdings | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 494.49 Mn |
| Jun 30, 2020 | 10.00 Mn |